Breckenridge W C, Alaupovic P, Cox D W, Little J A
Atherosclerosis. 1982 Aug;44(2):223-35. doi: 10.1016/0021-9150(82)90116-2.
Lipoprotein and apolipoprotein concentrations were determined in 11 homozygous and 9 heterozygous subjects for familial apolipoprotein C-II (Apo C-II) deficiency. Apo C-II was not detectable in the homozygotes, with the exception of 1 subject who possessed immunochemically detectable quantities in one of two samples. Apolipoproteins C-III (Apo C-III) and E (Apo E) were elevated 2-3-fold in 9 of 11 homozygotes. Apo C-III, but not Apo E, correlated with triglyceride levels (1500-4100 mg/dl). However, both Apo C-III and Apo E correlated with the cholesterol levels and one another. Apolipoproteins A-I (Apo A-I), A-II (Apo A-II) and B (Apo B) were reduced to approximately 50-60% of normal values in association with very low levels of cholesterol in high density (HDL; 11 +/- 2 mg/dl) and low density (LDL; 19 +/- 6 mg/dl) lipoproteins in the homozygous subjects. These alterations were associated with a marked decrease in the proportion of plasma Apo C-III associated with HDL. The levels of apolipoprotein D (Apo D) were within the normal range. Nine obligate heterozygotes had Apo C-II concentrations (mean 1.8 +/- 0.5 mg/dl; range 1.2-2.7 mg/dl) which were approximately 40-50% of normal values (mean 2.9 +/- 0.9 mg/dl; range 1.7-5.6 mg/dl). The reduction in absolute amounts of Apo C-II was also reflected in a reduction of the ratio Apo C-II/Apo C-III in very low density lipoproteins (VLDL) and in a reduction in the ability of the sera to activate skim milk lipoprotein lipase. The concentrations of Apo A-II, Apo B, Apo C-III and Apo E were normal. Apo A-I concentrations were normal or slightly low in association with slightly reduced concentrations of HDL cholesterol and a low proportion of plasma Apo C-III in HDL in relation to LDL and VLDL in some heterozygotes. It is concluded that the marked alterations in the apolipoprotein levels in homozygous subjects are primarily a reflection of the deficiency of Apo C-II which results in severe hypertriglyceridemia. In heterozygotes, the partial deficiency of Apo C-II appears to result in a minor disturbance of the clearance of the triglycerides and Apo C-III rich particles but no marked changes in the concentrations of total lipids, lipoproteins and apolipoproteins in fasting plasma.
在11名家族性载脂蛋白C-II(Apo C-II)缺乏症纯合子受试者和9名杂合子受试者中测定了脂蛋白和载脂蛋白浓度。在纯合子中检测不到Apo C-II,但有1名受试者在两份样本中的一份中具有免疫化学可检测量的Apo C-II。11名纯合子中的9名,载脂蛋白C-III(Apo C-III)和E(Apo E)升高了2至3倍。Apo C-III与甘油三酯水平(1500 - 4100mg/dl)相关,但Apo E不相关。然而,Apo C-III和Apo E都与胆固醇水平相关且彼此相关。在纯合子受试者中,载脂蛋白A-I(Apo A-I)、A-II(Apo A-II)和B(Apo B)降至正常值的约50 - 60%,同时高密度脂蛋白(HDL;11±2mg/dl)和低密度脂蛋白(LDL;19±6mg/dl)中的胆固醇水平极低。这些改变与血浆中与HDL相关的Apo C-III比例显著降低有关。载脂蛋白D(Apo D)水平在正常范围内。9名必然杂合子的Apo C-II浓度(平均1.8±0.5mg/dl;范围1.2 - 2.7mg/dl)约为正常值(平均2.9±0.9mg/dl;范围1.7 - 5.6mg/dl)的40 - 50%。Apo C-II绝对量的减少也反映在极低密度脂蛋白(VLDL)中Apo C-II/Apo C-III比值的降低以及血清激活脱脂乳脂蛋白脂肪酶能力的降低。Apo A-II、Apo B、Apo C-III和Apo E的浓度正常。在一些杂合子中,Apo A-I浓度正常或略低,同时HDL胆固醇浓度略有降低,且HDL中血浆Apo C-III相对于LDL和VLDL的比例较低。结论是,纯合子受试者载脂蛋白水平的显著改变主要反映了Apo C-II的缺乏,这导致了严重的高甘油三酯血症。在杂合子中,Apo C-II的部分缺乏似乎导致甘油三酯和富含Apo C-III颗粒清除的轻微紊乱,但空腹血浆中总脂质、脂蛋白和载脂蛋白的浓度没有明显变化。